<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Search4Dev / Wemos Foundation</title><link>http://www.search4dev.nl</link><description>Online library for Dutch development
										cooperation</description><language>en</language><copyright>www.kit.nl</copyright><managingEditor>dpcmedewerkers-uba@uva.nl</managingEditor><webMaster>dpcmedewerkers-uba@uva.nl</webMaster><lastBuildDate>Mon, 20 May 2013 23:10:54 CEST</lastBuildDate><image><url>/d/dprn/graphics/bbhead.gif</url><title>Search4Dev</title><link>http://www.search4dev.nl</link></image><item><guid>http://www.search4dev.nl/record/426264</guid><title>Jaarrapport 2011</title><link>http://www.search4dev.nl/record/426264</link><description>This is the annual account of Wemos Foundation for 2011. Wemos advocates for the right to health of people in developing countries. Wemos aims at strengthening national health systems that contribute to the structural improvement of people’s health in developing countries.</description><author>Stichting Wemos</author></item><item><guid>http://www.search4dev.nl/record/407687</guid><title>Jaarrapport 2010</title><link>http://www.search4dev.nl/record/407687</link><description>This is the annual account of Wemos Foundation for 2010. Wemos advocates for the right to health of people in developing countries. Wemos aims at strengthening national health systems that contribute to the structural improvement of people’s health in developing countries.</description><author>Stichting Wemos</author></item><item><guid>http://www.search4dev.nl/record/399057</guid><title>Protection of clinical trial participants in countries outside the EU</title><link>http://www.search4dev.nl/record/399057</link><description>Medicines intended for the European market are increasingly tested on clinical trial participants outside the EU in low and middle income countries. Over the past years, SOMO and Wemos have collected extensive evidence of violations of ethical principles and guidelines in such trials. In this briefing paper SOMO and Wemos provide the European Parliament, the European Commission and the European Medicines Agency(EMA) with policy recommendations to take their responsibility and address this problem.</description><author>SOMO</author><author>Wemos</author></item><item><guid>http://www.search4dev.nl/record/384346</guid><title>Global health advocate : annual report 2010</title><link>http://www.search4dev.nl/record/384346</link><description>This is the annual report of Wemos Foundation for 2010. Wemos advocates for the right to health of people in developing countries. Wemos aims at strengthening national health systems that contribute to the structural improvement of people’s health in developing countries.</description><author>Wemos Foundation</author></item><item><guid>http://www.search4dev.nl/record/381205</guid><title>Kansen grijpen : Nederlandse mogelijkheden om de ongelijke spreiding van zorgpersoneel wereldwijd te verbeteren</title><link>http://www.search4dev.nl/record/381205</link><description>The Dutch Alliance for Human Resources for Health is concerned about the global maldistribution of human resources for health (HRH), which particularly affects the health of people in developing countries. This publication presents measures, composed by the Alliance, to be taken by Dutch actors to improve the distribution of health staff across countries. The Dutch Alliance brings together a wide range of actors of the health and development cooperation sectors in the Netherlands: non-governmental organizations (NGOs), health professional organizations, labour unions, research institutions, HRH consultants, and other actors involved in the global shortage and international recruitment of health personnel. The Alliance joins forces and expertise, and aims to explore and promote policies and actions that are required for sufficient health staff and for strengthening health systems worldwide. This publication is to inspire Dutch stakeholders involved in training, recruitment, retention, and employment of health personnel to collaborate and undertake tailor-made actions, which jointly constitute a substantial Dutch contribution to global health.</description><author>C. Jansen</author></item><item><guid>http://www.search4dev.nl/record/367050</guid><title>Chances for change : Dutch measures to improve the global distribution of health personnel</title><link>http://www.search4dev.nl/record/367050</link><description>The Dutch Alliance for Human Resources for Health is concerned about the global maldistribution of human resources for health (HRH), which particularly affects the health of people in developing countries. This publication presents measures, composed by the Alliance, to be taken by Dutch actors to improve the distribution of health staff across countries. The Dutch Alliance brings together a wide range of actors of the health and development cooperation sectors in the Netherlands: non-governmental organizations (NGOs), health professional organizations, labour unions, research institutions, HRH consultants, and other actors involved in the global shortage and international recruitment of health personnel. The Alliance joins forces and expertise, and aims to explore and promote policies and actions that are required for sufficient health staff and for strengthening health systems worldwide. This publication is to inspire Dutch stakeholders involved in training, recruitment, retention, and employment of health personnel to collaborate and undertake tailor-made actions, which jointly constitute a substantial Dutch contribution to global health.</description><author>C. Jansen</author></item><item><guid>http://www.search4dev.nl/record/363517</guid><title>The globalization of clinical trials : testimonies from human subjects</title><link>http://www.search4dev.nl/record/363517</link><description>In this book, the Wemos Foundation presents the testimonies of people participating in clinical trials in Poland, Russia, the United States, China and India. Wemos would like to clarify the reasons why these people choose to participate and the way in which they are being treated. By collecting and publishing testimonies from trial subjects, their relatives and others investigating the issue, Wemos hopes to clarify how the right to health – the departure point for all activities of Wemos – is being respected or undermined. It also provides a voice to those who are seldom heard, allowing them to speak for themselves about their decision to participate in clinical trials, as well as about their experiences.</description><author>Wemos Foundation</author></item><item><guid>http://www.search4dev.nl/record/345468</guid><title>Health for all : jaarverslag 2009</title><link>http://www.search4dev.nl/record/345468</link><description>This is the annual report of Wemos Foundation for 2009. Wemos advocates for the right to health of people in developing countries. Wemos aims at strengthening national health systems that contribute to the structural improvement of people’s health in developing countries.</description><author>Stichting Wemos</author></item><item><guid>http://www.search4dev.nl/record/345467</guid><title>Health for all : annual report 2009</title><link>http://www.search4dev.nl/record/345467</link><description>This is the annual report of Wemos Foundation for 2009. Wemos advocates for the right to health of people in developing countries. Wemos aims at strengthening national health systems that contribute to the structural improvement of people’s health in developing countries.</description><author>Wemos Foundation</author></item><item><guid>http://www.search4dev.nl/record/339327</guid><title>Do European registration authorities ascertain whether clinical trials in developing countries have been conducted in an ethical manner? : a study</title><link>http://www.search4dev.nl/record/339327</link><description>The Wemos Foundation has conducted a study to examine the degree to which European registration authorities ascertain whether the clinical trials for new medicines have been conducted in accordance with the ethical guidelines. This report discusses the main findings of this study.</description><author>Wemos</author></item></channel></rss>